Skip to content

1. Current Status, Position

Mr Lorenz Van der Linden is currently working as a Hospital Pharmacist in a large teaching hospital (UZ Leuven, Belgium). His work focuses on investigating, developing and implementing clinical pharmacy services in selected patient populations (e.g. geriatric inpatients). 

2. Education

Mr Lorenz Van der Linden graduated as a hospital pharmacist in 2008, after which he followed a 2-year post-graduate course in clinical pharmacy. In 2018, he obtained his PhD (KULeuven, Belgium) for his work on improving drug use in older inpatients.

3. Research Area

Lorenz Van der Linden is invested in improving drug use and clinical outcome in complex, multimorbid and frequently polymedicated older persons.

4. Conflict of interest :

Mr Van der Linden is on the advisory board of Bayer and receives logistic support from this company. 

He used to receive speaker fees and logistic support from BMS/Pfizer and still receives speaker fees, logistic support and trial support from Daiichi Sankyo.

He used to receive logistic support from Sanofi.


×

Deadline extended to July 15th

Problems caused by shortages are serious, threaten patient care and require urgent action.

Help us provide an overview of the scale of the problem, as well as insights into the impact on overall patient care.

Our aim is to investigate the causes of medicine and medical device shortages in the hospital setting,  while also gathering effective solutions and best practices implemented at local, regional, and national levels.

×

Join us in Prague for the 2nd edition of BOOST!

Secure your spot in the Movement for Shortage-Free World

BOOST is where visionaries, innovators, and healthcare leaders come together to tackle one of the biggest challenges in hospital pharmacy—medicine shortages.